@article{13042d72a1eb464cb905fdb4c389d26e,
title = "Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2",
keywords = "body weight, empagliflozin, glucose, infarct size, ischemia/reperfusion, ketones, sodium-glucose cotransporter 2 inhibitor",
author = "Sha Chen and Qian Wang and Andriana Christodoulou and Nikolaos Mylonas and Diane Bakker and Rianne Nederlof and Hollmann, {Markus W.} and Weber, {Nina C.} and Ruben Coronel and Vincent Wakker and Christoffels, {Vincent M.} and Ioanna Andreadou and Zuurbier, {Coert J.}",
note = "Funding Information: Dr Zuurbier received a research grant from Boehringer Ingelheim. The other authors report no conflicts.",
year = "2023",
month = jan,
day = "17",
doi = "https://doi.org/10.1161/CIRCULATIONAHA.122.061688",
language = "English",
volume = "147",
pages = "276--279",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "3",
}